SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-04-003414
Filing Date
2004-04-20
Accepted
2004-04-20 08:32:21
Documents
2
Period of Report
2004-04-20
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS a4619084.txt 8-K 3138
3 PRESS RELEASE a4619084ex991.txt EX-99 8583
  Complete submission text file 0001157523-04-003414.txt   13400
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 04741719
SIC: 2836 Biological Products, (No Diagnostic Substances)